The Board of Scancell Holdings Plc, (AIM: SCLP), the developer of therapeutic cancer vaccines, announce the appointment of Matrix Corporate Capital LLP as joint broker with immediate effect.

For further information contact:

Professor Lindy Durrant - Scancell Holdings Plc

• + 44 (0)207 245 1100

John Bick/Kirsty Corcoran - Hansard Communications

• + 44 (0)207 245 1100

Ross Andrews/Tom Rowley - Zeus Capital - Nominated Adviser/Joint Broker

• + 44 (0)161 831 1512

Robert Naylor/Stephen Waterman - Matrix Corporate Capital LLP - Joint Broker

• +44 (0)20 3206 7340

View the full Document